Company Directory

3P Innovation is an engineering company with a reputation for providing innovative solutions to major pharmaceutical and medical companies, by providing customers with a range of services including high specification manufacturing equipment, special purpose and custom machinery.

4P Therapeutics develops drug delivery technologies and therapeutics, from preclinical testing to clinical manufacturing and early clinical (Phase I/II), with a focus on transdermal products for currently injected compounds, including biologics. 4P is a subsidiary of Nutriband, Inc.

Aardex Group provides digital solutions to measure and manage medication adherence, including digital solutions for adherence-enhancing strategies in clinical trials, research settings and professional healthcare systems, to enhance digital therapeutics and patient empowerment.

ABITEC's pharmaceutical division develops and manufactures highly functional and reproducible, monograph-compliant lipid-based excipients for drug delivery applications, to enhance the bioavailability of poorly water-soluble and poorly permeable APIs, across multiple delivery routes.

Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products. Services and technologies with applications within the drug delivery field include antibody-drug conjugates and PEGylation.

Accu-Break Pharmaceuticals has invented, developed and patented a suite of novel Accu-Break technologies that enable pharmaceutical tablets to be made that can be subdivided by hand into accurate partial doses with the intent of making it easier and safer for patients to adjust their dose.

ACG is one of the largest manufacturer of empty hard capsules in the world, offering a complete range of solutions beginning with empty capsules, granulation and coating, capsule filling, tabletting, packaging films, blister packing and carton packing, to end-of-line solutions.

Acorda Therapeutics develops therapies to improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. It manufactures and markets Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the US. Its ARCUS technology transforms medicines into light, respirable dry powders. 

Adare Pharmaceuticals is a technology-driven CDMO providing product development through to commercial manufacturing expertise focused on oral dosage forms. Adare’s proprietary technology portfolio encompasses ODT’s, taste masking and customised drug release.